Echo Research and Practice,
Journal Year:
2025,
Volume and Issue:
12(1)
Published: March 5, 2025
Patients
with
moderate
aortic
stenosis
(AS)
may
experience
symptoms
and
adverse
outcomes.
The
aim
of
this
study
was
to
determine
whether
patients
AS
exhibited
objective
evidence
exercise
limitation,
compared
age
sex
matched
controls
if
so,
which
echocardiographic
parameters
predicted
ability.
This
a
prospective
case
control
(peak
velocity
(Vmax)
3.0-3.9
m/s,
mean
gradient
(MG)
20-39mmHg,
valve
area
(AVA)1.1-1.5cm2
)
left
ventricular
ejection
fraction
(LVEF)
≥
55%.
All
underwent
cardiopulmonary
stress
echocardiography.
25
(Vmax
3.5
±
0.2mmHg,
28
5mmHg,
AVA
1.2
0.1cm2,
LVEF
61
4%)
were
controls.
%
oxygen
uptake
efficiency
slope
(OUES),
O2
pulse
VO2
at
anaerobic
threshold
(AT)
significantly
lower
in
(OUES
79
15
vs.
89
15%,
p
=
0.013).
did
not
differ
between
cases
Objective
measures
capacity
including
OUES,
AT
are
controls,
suggesting
that
these
be
more
useful
than
where
unable
complete
maximal
test.
Risk
stratification
using
echocardiography
help
identify
who
increased
risk
cardiovascular
events
should
considered
for
intensive
surveillance
intervention.
Clinical
trial
number
MRC
0225
IRAS
207395.
European Journal of Cardiovascular Nursing,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 13, 2025
Abstract
Aims
This
study
aims
to
investigate
the
latent
profiles
and
influencing
factors
of
fear
progression
(FoP)
among
patients
following
cardiac
valve
replacement
(CVR)
explore
mechanisms
FoP
its
primary
factors.
Methods
results
cross-sectional
included
385
who
had
undergone
CVR
in
Hunan
Province,
China.
Data
on
FoP,
Type
D
personality,
death
anxiety,
medical
coping
modes,
family
function
were
collected
using
appropriate
questionnaires.
A
serial
multiple
mediation
model
was
utilized
evaluate
effects
FoP.
The
average
score
35.59
±
8.21,
with
191
exhibiting
high
levels.
Family
negatively
affected
resignation
mode
(β
=
−0.255,
P
<
0.001),
anxiety
−0.145,
−0.363,
0.001).
Resignation
demonstrated
a
chain
mediating
role
−0.036,
0.001)
between
accounting
for
13.84%
total
indirect
effect.
Latent
profile
analysis
identified
four
profiles:
‘low-risk
group’
(8.05%),
‘moderate-risk
(42.33%),
‘high-risk
(34.54%),
‘severe-risk
(15.06%).
Patients
levels
monthly
household
income
<3000
RMB,
adoption
avoidance
or
modes
(all
0.05)
more
likely
be
classified
into
‘Severe
group.’
Conclusion
have
exhibit
heterogeneous
profiles,
49.60%
showing
severe
members
clinical
staff
should
focus
risk
provide
targeted
prevention
strategies
psychological
care
according
characteristics
distinct
profiles.
Cardiovascular Diabetology,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: March 5, 2025
Aortic
valve
calcification
(AVC)
is
an
underlying
pathophysiological
mechanism
in
aortic
stenosis,
which
shares
many
risk
factors
with
diabetes.
However,
the
association
between
dysglycemia
and
early
stages
of
AVC
remains
unclear.
The
aim
was
to
examine
associations
signs
among
middle-aged
individuals
from
general
population.
This
a
cross-sectional
study
Swedish
CArdioPulmonary
bioImage
Study
(SCAPIS)
randomly
enrolling
30,154
men
women
six
sites
Sweden
2013
2018.
Glycemic
status
based
on
World
Health
Organization
criteria
(fasting
blood
glucose
and/or
HbA1c)
questionnaire-based
answers
previous
diseases
categorized
as
normoglycemia,
prediabetes,
newly
detected
diabetes
known
assessed
cardiac
computed
tomography
(CT)
defined
evident
or
not.
Of
29,331
data
glycemic
available,
mean
age
57.5
years
normoglycemia
present
76%,
prediabetes
16%,
3%
5%.
prevalence
increased
progressively
across
categories,
particularly
males
(8%,
11%,
14%
17%;
P
<
0.01)
compared
females
(5%,
6%,
8%
9%;
0.01).
There
already
dysglycemia;
(OR
1.16,
95%
CI
1.02-1.31),
(1.34
[1.05-1.71])
(1.61
[1.34-1.93])
after
adjusting
for
age,
sex,
smoking,
site,
low
density
lipoprotein-cholesterol
hypertension.
In
this
large,
contemporary,
selected
population
individuals,
were
all
associated
CT-detected
AVC.
Further
studies
are
warranted
investigate
if
managing
dysglycemia,
even
its
stages,
may
help
slow
down
progression.
Materials Today Bio,
Journal Year:
2024,
Volume and Issue:
28, P. 101194 - 101194
Published: Aug. 10, 2024
Valvular
heart
diseases
(VHDs)
have
become
one
of
the
most
prevalent
worldwide,
and
prosthetic
valve
replacement
is
effective
treatments.
With
fast
development
minimal
invasive
technology,
transcatheter
valves
has
been
exploring
in
recent
years,
such
as
aortic
(TAVR)
technology.
In
addition,
basic
research
on
begun
to
shift
from
traditional
mechanical
biological
polymeric
valves.
The
(PHVs)
shown
a
bright
future
due
their
advantages
longer
durability,
better
biocompatibility
reduced
cost.
This
review
gives
brief
history
valves,
provides
summary
types
polymer
materials
suitable
for
leaflets
emerging
processing/preparation
methods
research.
Besides,
we
facilitate
deeper
understanding
products
that
are
currently
preclinical/clinical
studies,
also
limitations
present
researches
well
trends.
Hence,
this
will
provide
holistic
researchers
working
field
offer
ideas
design
with
durability
biocompatibility.
Algorithms,
Journal Year:
2024,
Volume and Issue:
17(8), P. 364 - 364
Published: Aug. 19, 2024
Heart
diseases
such
as
cardiovascular
and
myocardial
infarction
are
the
foremost
reasons
of
death
in
world.
The
timely,
accurate,
effective
prediction
heart
is
crucial
for
saving
lives.
Electrocardiography
(ECG)
a
primary
non-invasive
method
to
identify
cardiac
abnormalities.
However,
manual
interpretation
ECG
recordings
disease
diagnosis
time-consuming
inaccurate
process.
For
accurate
efficient
detection
from
12-lead
dataset,
we
have
proposed
hybrid
residual/inception-based
deeper
model
(HRIDM).
In
this
study,
utilized
datasets
various
sources,
which
multi-institutional
large
datasets.
trained
on
data
over
10,000
patients.
We
compared
with
several
state-of-the-art
(SOTA)
models,
LeNet-5,
AlexNet,
VGG-16,
ResNet-50,
Inception,
LSTM,
same
training
test
To
show
effectiveness
computational
efficiency
model,
only
20
epochs
without
GPU
support
achieved
an
accuracy
50.87%
dataset
27
categories
found
that
our
outperformed
previous
studies
participated
official
PhysioNet/CinC
Challenge
2020
fourth
place
41
ranking
teams.
result
study
indicates
implying
new
predicting
using
ECGs.
Valvular
heart
disease
(VHD),
clinically
manifested
as
a
malfunction
of
valves,
greatly
threatens
public
health
worldwide.
The
morbidity
and
mortality
VHD
increase
significantly
with
age,
the
high
prevalence
in
aging
society
has
prompted
urgency
for
effective
treatment.
Prosthetic
valve
replacement
is
currently
recognized
gold
standard
Bioprosthetic
valves
(BHVs),
generally
manufactured
from
glutaraldehyde
crosslinked
xenogeneic
tissue,
exhibited
better
hemodynamics
lower
thrombogenicity
than
mechanical
(MHVs)
could
be
implanted
by
transcatheter
systems,
which
markedly
improved
efficiency
therapy,
especially
elderly
patients.
However,
BHVs
degenerated
within
10-15
years
after
implantation,
associated
their
defects
including
cytotoxicity,
calcification,
immune
response,
matrix
degradation,
damage,
thrombosis.
To
prolong
service
life
BHVs,
recent
studies
have
developed
series
innovative
modification
strategies
to
improve
biocompatibility,
performance,
components
stability,
anticalcification,
antithrombotic
properties
conventional
BHVs.
Moreover,
new
crosslinking
were
proposed
fabricate
non-glutaraldehyde
good
hemocompatibility,
anticalcification
property,
durability,
hydrodynamics.
In
this
review,
we
first
summarized
related
reasons
biomaterials
perspective,
then
comprehensively
detailed
functional
based
on
crosslinking.
We
provided
insights
into
novel
Finally,
current
challenges
prospects
also
discussed.
Acta Cardiologica,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 12
Published: Jan. 28, 2025
Previous
studies
have
shown
that
valvular
heart
disease
(VHD)
is
closely
related
to
the
development
of
heart-related
(HRD).
However,
current
research
for
relationship
between
VHD
and
HRD
complex
poorly
targeted.
Meanwhile,
these
lack
support
bibliometric
analysis
results.
Our
study
focused
on
a
published
papers
HRDs.
The
also
attempted
identify
primary
authors,
institutions
countries
analyse
status
trends
PubMed
database
was
searched
publications
2000
2023.
Python
v3.10.8,
R
v4.2.2
VOSviewer
v1.6.18
software
tools
were
utilised
perform
this
visualisation.
There
4,235
qualified
found
in
total,
with
annual
number
increasing.
According
co-occurrence
keywords,
we
main
directions
are
age,
gender,
diagnosis
treatment.
Newly
emerging
mainly
focuses
failure,
which
relatively
VHD.
These
results
provided
useful
perspective
future
prospects
link
HRD,
could
help
researchers
select
partners
facilitate
their
elucidate
underlying
molecular
mechanisms
including
causes,
prevention,
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 8, 2025
ABSTRACT
Calcific
aortic
valve
disease
currently
lacks
effective
treatments
beyond
surgical
replacement,
due
to
an
incomplete
understanding
of
its
pathogenesis.
Emerging
evidence
suggests
that
the
gut
microbiome
influences
cardiovascular
health
through
production
metabolites
derived
from
dietary
components.
Among
them,
trimethylamine-N-oxide
(TMAO)
has
been
identified
as
a
potential
causal
factor
for
several
conditions.
However,
role
in
development
remains
poorly
understood.
This
study
sought
investigate
impact
TMAO
on
valvular
interstitial
cells
(VICs),
most
abundant
cell
type
valve.
Here,
we
demonstrate
activates
VICs
towards
myofibroblastic
profibrotic
phenotype.
Using
vitro
protocol
generate
quiescent
VICs,
found
induces
upregulation
markers
sex-independent
manner.
These
were
more
sensitive
than
conventionally
cultured
VICs.
Treatment
with
also
elevated
extracellular
matrix
and
oxidative
stress,
phenotypic
hallmarks
activated
state.
Finally,
inhibition
endoplasmic
reticulum
stress
kinase
prior
treatment
blocked
all
effects
this
metabolite.
findings
suggest
contributes
early
stages
by
promoting
VIC
activation
mechanisms.
Understanding
other
gut-derived
pathogenesis
could
inform
novel
preventive
or
therapeutic
strategies
modify
delay
progression.
Furthermore,
these
insights
underscore
importance
host-microbiome
interactions
highlight
targeted
interventions
mitigate
risk.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 8, 2025
To
analyze
and
compare
the
differences
in
mortality,
healthcare
utilization,
costs
between
patients
with
symptomatic
asymptomatic
isolated
aortic
insufficiency
(AI).
We
utilized
Optum
United
Health
Care
Database
for
US
who
had
an
AI
claim
2017
2022,
12
months
of
continuous
enrollment
(baseline
period)
prior
to
diagnosis.
Exclusion
criteria
were
AVR
during
baseline
period
or
a
diagnosis
stenosis.
Patients
split
into
two
cohorts:
those
symptoms
(SAI)
without
(AAI).
SAI
≥
2
visits
heart
failure,
angina,
dyspnea,
syncope
at
baseline.
Outcomes
interest
all-cause
time
home
health,
SNF,
annualized
costs.
used
Cox
proportional
model
estimate
mortality
general
linear
models
utilization
modeled
separately.
Of
249,660
patients,
58.23%
symptomatic;
they
generally
older
sicker
than
AAI
cohort,
less
1%
received
AVR.
Almost
half
estimated
develop
within
5
years
post-diagnosis.
outcomes
consistently
higher
across
all
measured
outcomes.
have
AAI.
However,
can
progress
quickly
from
symptomatic.
Early
detection
timely
interventions
slow
progression
address
it
surgically
should
be
emphasized
limit
impact
AI.